Skip to content

    Cancer Health Center

    Font Size
    A
    A
    A

    FDA Eyes Anemia Drugs' Cancer Risk Again

    FDA Notes 'Further Evidence' of Cancer Risk From Anemia Drugs Known as ESAs
    By
    WebMD Health News
    Reviewed by Louise Chang, MD

    Jan. 3, 2008 -- The FDA today announced that it's reviewing more data on cancer risks tied to the anemia drugs Aranesp, Epogen, and Procrit.

    Those drugs are erythropoiesis-stimulating agents (ESAs). They boost production of red blood cells and already bear a "black box warning" (the FDA's toughest warning) about cancer risk.

    That warning, launched in March 2007 and revised in November 2007, is based on six studies. Now, the FDA is reviewing two more studies from Amgen, the company that makes all three ESAs.

    An FDA advisory committee will discuss the data and revisit the drugs' risks and benefits in the next few months.

    Meanwhile, the FDA advises doctors and patients to review and discuss the risks and benefits of ESAs outlined in the product label.

    The new studies provide "further evidence" of the drugs' risks, states an FDA news release.

    The FDA notes that together, all eight studies (including the two new studies) show that tumors grew faster and survival rates were worse among patients with breast, non-small-cell lung, head and neck, lymphoid, or cervical cancers who took ESAs compared with those who weren't taking those drugs.

    An FDA advisory committee will discuss the data and revisit the drugs' risks and benefits in the next few months.

    Amgen provided the two new studies to the FDA in late November and early December 2007, according to the FDA. While Amgen makes all three ESAs, Procrit is marketed and distributed by Ortho Biotech LP, a subsidiary of Johnson & Johnson.

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article